The Arab Drug Company Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Millions EGP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	112.14	79.28	232.72	50.48	40.28	46.43
Short-Term Investments	-	-	-	-	-	13.88
Cash & Short-Term Investments	112.14	79.28	232.72	50.48	40.28	60.31
Cash Growth	-39.90%	-65.93%	361.00%	25.33%	-33.21%	-17.65%
Accounts Receivable	154.3	130.06	71.44	69.72	54.02	33.56
Other Receivables	86.26	76.36	48.45	20.11	28.91	15.54
Receivables	345.08	287.39	203.53	173.07	153.86	142.07
Inventory	309.36	327.72	236.28	254.09	224.85	171.7
Prepaid Expenses	-	-	0.01	-	0.11	0.1
Other Current Assets	-	0.74	0.34	0.41	0.43	0.93
Total Current Assets	766.58	695.12	672.88	478.05	419.53	375.11
Property, Plant & Equipment	624.81	616.53	444.4	193.36	145.5	59.19
Long-Term Investments	2.26	2.26	2.26	2.26	2.26	3.24
Long-Term Deferred Tax Assets	5.68	8.98	14.06	8.39	6.7	8.73
Other Long-Term Assets	-	-	-0	-	-0	-
Total Assets	1,399	1,323	1,134	682.07	573.98	446.27
Accounts Payable	69.84	64.52	45.63	44.18	25.26	20.45
Accrued Expenses	76.93	9.48	11.63	11.14	9.02	10.07
Short-Term Debt	198.81	174.41	116.7	85.26	98.66	21.21
Current Portion of Long-Term Debt	91.44	91.44	73.37	-	-	-
Current Income Taxes Payable	-	48.72	24.42	6.33	2.41	24.76
Other Current Liabilities	172.11	68.26	76.3	45.11	46.01	60.15
Total Current Liabilities	609.13	456.83	348.04	192.03	181.36	136.63
Long-Term Debt	237.87	245.35	324.88	103.71	52.41	-
Long-Term Leases	0.45	0.96	2.15	3.1	-	-
Other Long-Term Liabilities	-	-	-	0	-	-
Total Liabilities	847.45	703.15	675.06	298.84	233.78	136.63
Common Stock	120	120	60	60	60	60
Retained Earnings	410.58	478.45	377.23	301.94	258.91	227.36
Comprehensive Income & Other	21.3	21.3	21.3	21.3	21.3	22.27
Shareholders' Equity	551.88	619.74	458.53	383.23	340.21	309.63
Total Liabilities & Equity	1,399	1,323	1,134	682.07	573.98	446.27
Total Debt	528.57	512.16	517.09	192.07	151.07	21.21
Net Cash (Debt)	-416.43	-432.88	-284.38	-141.59	-110.8	39.1
Net Cash Growth	-	-	-	-	-	-33.99%
Net Cash Per Share	-34.70	-36.07	-23.70	-11.80	-8.18	2.82
Filing Date Shares Outstanding	12	12	12	12	12	12
Total Common Shares Outstanding	12	12	12	12	12	12
Working Capital	157.45	238.29	324.84	286.03	238.17	238.48
Book Value Per Share	45.99	51.65	38.21	31.94	28.35	25.80
Tangible Book Value	551.88	619.74	458.53	383.23	340.21	309.63
Tangible Book Value Per Share	45.99	51.65	38.21	31.94	28.35	25.80
Land	0.36	0.36	0.36	0.36	0.36	0.36
Buildings	272.59	272.24	82.98	61.47	61.44	49.42
Machinery	210.85	208.66	145.17	124.79	124.52	118.84
Construction In Progress	333.65	318.45	372.62	154.6	101.16	25.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.